Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.37 |
| ▸ | HTT | P42858 | 4/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.32 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.32 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.32 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9847498 | 0.75 | SMN1; SMN2 (0.31) | SMN1; SMN2 | |
| SCHEMBL2493319 | 0.74 | SMN1; SMN2 (0.33) | SMN1; SMN2 | |
| SCHEMBL5243332 | 0.74 | SMN1; SMN2 (0.43) | SMN1; SMN2ALDH1A1HTTLMNAMAPT | |
| Hydrochloric Acid SCHEMBL7688487 | 0.72 | SMN1; SMN2 (0.32) | SMN1; SMN2 | |
| SCHEMBL38953 | 0.71 | SMN1; SMN2 (0.56) | SMN1; SMN2ALDH1A1HTTLMNACYP2C19 | |
| Water SCHEMBL4837114 | 0.69 | SMN1; SMN2 (0.54) | SMN1; SMN2ALDH1A1LMNACYP2C19KDM4E | |
| Iodide SCHEMBL11830139 | 0.69 | SMN1; SMN2 (0.54) | SMN1; SMN2ALDH1A1LMNACYP2C19KDM4E | |
| Hydrochloric Acid SCHEMBL20704047 | 0.69 | SMN1; SMN2 (0.54) | SMN1; SMN2ALDH1A1LMNACYP2C19KDM4E | |
| Water SCHEMBL7733637 | 0.69 | SMN1; SMN2 (0.54) | SMN1; SMN2ALDH1A1LMNACYP2C19KDM4E | |
| SCHEMBL29829697 | 0.69 | SMN1; SMN2 (0.54) | SMN1; SMN2ALDH1A1LMNACYP2C19KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 152 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0035889-B1 | ALKYL-METAL COCATALYST | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1984-05-02 | — | — | EP | claimed |
| EP-4568764-B1 | INTEGRATION OF A HEAT PUMP CIRCUIT INTO A DISTILLATION PLANT FOR POLYMERIZABLE SUBSTANCES | BASF SE (DE) | 2026-04-29 | — | — | EP | disclosed |
| EP-4543865-B1 | PROCESS FOR PREPARING SOLKETAL ACRYLATE BY TRANSESTERIFICATION | BASF SE (DE) | 2026-04-29 | — | — | EP | disclosed |
| US-20260008742-A1 | CONTINUOUS PROCESS FOR PRODUCING N-BUTYL (METH)ACRYLATE WITH A CATALYST RECIRCULATION SYSTEM | BASF SE (DE) | 2026-01-08 | — | — | US | disclosed |
| WO-2025261823-A1 | PROCESS FOR MANUFACTURE OF (METH)ACRYLATES | BASF SE (DE) | 2025-12-26 | — | — | WO | disclosed |
| US-20250282705-A1 | PREPARATION OF TERMINALLY UNSATURATED (METH)ACRYLATE CROSSLINKERS | RÖHM GMBH (DE) | 2025-09-11 | — | — | US | disclosed |
| EP-4613785-A1 | ESTER-COMPOUND-CONTAINING COMPOSITION AND METHOD FOR PRODUCING SAME, POLYMERIZABLE COMPOSITION, AND (METH)ACRYLIC POLYMER AND METHOD FOR PRODUCING SAME | Mitsubishi Chemical Corporation (JP) | 2025-09-10 | — | — | EP | disclosed |
| EP-4613784-A1 | ESTER COMPOUND-CONTAINING COMPOSITION, METHOD FOR PRODUCING SAME, POLYMERIZABLE COMPOSITION, (METH)ACRYLIC POLYMER, AND METHOD FOR PRODUCING SAME | Mitsubishi Chemical Corporation (JP) | 2025-09-10 | — | — | EP | disclosed |
| EP-4610284-A1 | MONOMER COMPOSITION, METHACRYLIC RESIN COMPOSITION AND PRODUCTION METHOD THEREFOR, AND MOLDED RESIN OBJECT | Mitsubishi Chemical Corporation (JP) | 2025-09-03 | — | — | EP | disclosed |
| EP-4419580-B1 | METHOD FOR PROMOTING HYDROSILYLATION REACTION TO PREPARE ESTER-FUNCTIONAL SILOXANE OLIGOMERS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-08-27 | — | — | EP | disclosed |
| CN-1202050-C | Polymerization inhibiting method for ethenyl chemical compound | NIPPON CATALYTIC CHEM IND (JP) | 2005-05-18 | — | — | CN | disclosed |
| US-20050077240-A1 | Rectificative separation of an acrylic acid-containing liquid | BASF AKTIENGESELLSCHAFT (DE) | 2005-04-14 | — | — | US | disclosed |
| EP-1427692-A1 | METHOD FOR PRODUCING (METH)ACRYLIC ACID ESTERS | BASF AKTIENGESELLSCHAFT (DE) | 2004-06-16 | — | — | EP | disclosed |
| US-20040031674-A1 | Workup of (meth)acrylic acid and (meth)acrylic esters | BASF AKIENGESELLSCHAFT (DE) | 2004-02-19 | — | — | US | disclosed |
| WO-2003022793-A1 | METHOD FOR PRODUCING (METH)ACRYLIC ACID ESTERS | BASF AKTIENGESELLSCHAFT (DE) | 2003-03-20 | — | — | WO | disclosed |
| CN-1243115-A | Polymerization inhibiting method for ethenyl chemical compound | NIPPON CATALYTIC CHEM IND (JP) | 2000-02-02 | — | — | CN | disclosed |
| US-5583188-A | USING TITANIUM, ORGANOALUMINUM, NITROGEN OR OXYGEN HETEROCYCLE CONTAINING CATALYST | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1996-12-10 | — | — | US | disclosed |
| US-4678767-A | COORDINATION CATALYST YIELDING POLYMERS OF HIGH BULK DENSITY | TOA NENRYO KOGYO KABUSHIKI KAISHA (JP) | 1987-07-07 | — | — | US | disclosed |
| EP-0086644-B1 | CATALYST COMPOSITION AND PROCESS FOR POLYMERIZING OLEFINS | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1987-05-06 | — | — | EP | disclosed |
| EP-0086644-A2 | Catalyst composition and process for polymerizing olefins | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1983-08-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250282705-A1 | PREPARATION OF TERMINALLY UNSATURATED (METH)ACRYLATE CROSSLINKERS | MTHFD2, MMAB, PAM | SMN1; SMN2 3657/4885ALDH1A1 153/4885HTT 51/4885 |
| US-20260008742-A1 | CONTINUOUS PROCESS FOR PRODUCING N-BUTYL (METH)ACRYLATE WITH A CATALYST RECIRCULATION SYSTEM | MMAB, ALKBH1, ALKBH3 | SMN1; SMN2 806/4885ALDH1A1 134/4885HTT 2033/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.